PKM and breast cancer: A recent study revealed that cryptotanshinone significantly reduced BC migration and invasion, possibly through the suppression of the PKM2/β-catenin pathway and the overexpression of PKM2, which decreased cryptotanshinone sensitivity in BC cells (54).